Compared to insulin glargine however, insulin detemir has a shorter duration of action, and therefore may need to be given twice a day, particularly in patients with type 1 diabetes (Fig. 11C, Table 2) (54). This evidence concerns the gene INS and type 1 diabetes mellitus.